Austin, TX -- (SBWIRE) -- 04/26/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following stock:-
Advanced Micro Devices, Inc. (NYSE:AMD) shares decreased 2.24% to $2.62. The company, on April 18, announced revenue for the first quarter of 2013 of $1.09 billion, an operating loss of $98 million and a net loss of $146 million, or $0.19 per share. The company reported a non-GAAP operating loss of $46 million and a non-GAAP net loss of $94 million, or $0.13 per share.
Additionally, the company on April 24 launched the AMD Radeon™ HD 7990, the world's fastest graphics card1, designed for gamers who want to take their PC gaming experience to the highest level.
Can AMD Recover After The Recent fall? Find Out Here
Pfizer Inc.(NYSE:PFE) shares declined 0.89% to $30. The board of directors of Pfizer Inc. on April 25 declared a 24-cent second-quarter 2013 dividend on the company's common stock, payable June 4, 2013, to shareholders of record at the close of business on May 10, 2013. The second-quarter 2013 cash dividend will be the 298th consecutive quarterly dividend paid by Pfizer.
Additionally, the company, on April 25, said an advisory committee to European regulators has recommended against the approval of its new rheumatoid arthritis drug, dealing a setback to the drug giant's plans to bring the drug overseas. The drug, called Xeljanz, late last year was approved in the U.S. to treat adults with moderate to severe rheumatoid arthritis who have had a poor response to methotrexate.
Can PFE Continue To Move Higher? Find Out Here
Starbucks Corporation(NASDAQ:SBUX) shares declined 1.07% to $59.85. The company, on April 25, reported higher quarterly profit that matched estimates and it raised its full-year earnings forecast.
The company said net earnings rose to $390.4 million, or 51 cents per share, in the fiscal second quarter that ended on March 31 from $309.9 million, or 40 cents per share, a year earlier. Adjusted earnings were 48 cents per share, matching analysts' average estimate. Revenue rose 11 percent to $3.56 billion. Analysts were expecting $3.59 billion. The company said it expects earnings of $2.12 to $2.18 per share this year, up from a prior target range of $2.06 to $2.15.
How Should Investors Trade SBUX Now? Find Out Here
Jackpotpennystocks.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
The assembled information disseminated by Jackpotpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Jackpotpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)